Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai's next Alzheimer's prospect

Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai's next Alzheimer's prospectaliuFri, 01/21/2022 - 06:45